BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32016624)

  • 1. Microbleeds in dementia with Lewy bodies.
    Donaghy PC; Firbank M; Mitra D; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    J Neurol; 2020 May; 267(5):1491-1498. PubMed ID: 32016624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
    Mak E; Donaghy PC; McKiernan E; Firbank MJ; Lloyd J; Petrides GS; Thomas AJ; O'Brien JT
    Neurobiol Aging; 2019 Jan; 73():74-81. PubMed ID: 30339962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
    Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
    Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
    Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
    Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
    Siderowf A; Pontecorvo MJ; Shill HA; Mintun MA; Arora A; Joshi AD; Lu M; Adler CH; Galasko D; Liebsack C; Skovronsky DM; Sabbagh MN
    BMC Neurol; 2014 Apr; 14():79. PubMed ID: 24716655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microbleeds in dementia with Lewy bodies.
    Chin KS; Hijazi Z; Churilov L; Gajamange S; Desmond PM; Villemagne V; Rowe C; Yassi N; Watson R
    Parkinsonism Relat Disord; 2022 Nov; 104():68-71. PubMed ID: 36252391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
    J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease.
    Gungor I; Sarro L; Graff-Radford J; Zuk SM; Tosakulwong N; Przybelski SA; Lesnick T; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Filippi M; Petersen RC; Jack CR; Kantarci K
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1101-4. PubMed ID: 26205074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cerebral microbleeds with cerebrospinal fluid Alzheimer-biomarkers and clinical symptoms in early dementia with Lewy bodies.
    Mendes A; Noblet V; Mondino M; Loureiro de Sousa P; Manji S; Archenault A; Casanovas M; Bousiges O; Philippi N; Baloglu S; Rauch L; Cretin B; Demuynck C; Martin-Hunyadi C; Blanc F
    Int J Geriatr Psychiatry; 2021 Jun; 36(6):851-857. PubMed ID: 33300151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.
    Whitwell JL; Kantarci K; Weigand SD; Lundt ES; Gunter JL; Duffy JR; Strand EA; Machulda MM; Spychalla AJ; Drubach DA; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    J Alzheimers Dis; 2015; 45(4):1109-17. PubMed ID: 25649655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
    J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T; Kameyama M
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Am J Geriatr Psychiatry; 2020 May; 28(5):573-577. PubMed ID: 31953009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.